CHEMCON2021-10-012021-12-31in-bse-fin:OneOperatingExpenses01Member CHEMCON2021-10-012021-12-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares CHEMCON 2021-04-01 2022-03-31 2022-01-29 INR Lakhs Third quarter Single segment Specialty Chemicals 2021-10-01 2021-12-31 Unaudited Standalone 495402000.00 23311000.00 518714000.00 249784000.00 33672000.00 -93422000.00 49508000.00 1050000.00 15510000.00 82575000.00 338676000.00 180037000.00 0.00 180037000.00 45095000.00 80000.00 45174000.00 0.00 134863000.00 0.00 0.00 0.00 0.00 134863000.00 -95000.00 134768000.00 134768000.00 0.00 366307000.00 10 3.68 3.68 0.00 0.00 3.68 3.68 Notes : 1. These unaudited Financial results have been prepared in accordance with the recognition and measurement principles of Indian Accounting Standards ( Ind AS ) prescribed under section 133 of the Companies Act, 2013 and read with the relevant rules issued thereunder and the other accounting principles generally accepted in India. 2. The above unaudited financial results have been reviewed by Audit Committee and the Board of Directors have approved the above results at their meeting held on February 7, 2022 and have been subject to a limited review by the statutory auditors of the Company. 3. The Company is in the business of manufacturing of Specialty Chemicals for Pharmaceutical and Oilfield Chemicals (Completion Fluids) industries. There is only one reportable segment in accordance with Ind AS 108 - Operating Segments. 4. The Company has offered through the Initial Public Offer (IPO) 93,52,941 Equity Shares having face value of Rs. 10/- each at an issue price of Rs. 340/- per Equity Share, comprising offer for sale of 45,00,000 equity shares by Selling Shareholders and fresh issue of 48,52,941 equity shares. These equity shares were allotted on September 29, 2020 and were listed on October 1, 2020 on BSE Limited and National Stock Exchange of India Limited. 5. The utilisation of the net IPO proceeds is summarised below: Funding Capital expenditure towards expansion of Manufacturing Facility- As per objects: Rs. 4,103.30, Revised Cost Rs. 4,103.30, utilisation till 31-Dec-21: Rs.4,103.30 and Unutilised amounts as on 31-Dec-21: Rs. 0.00 Funding Incremental working capital requirement- As per objects: Rs. 9,000.00, Revised Cost Rs. 9,000.00, utilisation till 31-Dec-21: Rs.4,000.00 and Unutilised amounts as on 31-Dec-21: Rs. 5,000.00 Funding General corporate purposes* - As per objects: Rs. 1,875.50, Revised Cost Rs. 1,924.68, utilisation till 31-Dec-21: Rs. 1,433.60and Unutilised amounts as on 31-Dec-21: Rs. 488.00 * The revision in General corporate purposes expenses is on account of reduction in offer expenses on actual booking as compared to estimated. IPO Proceeds which were unutilised as at 31-Dec-21 were temporarily invested in deposits with scheduled commercial bank. ***Please refere note 6, 7, and 8 from filed PDF version due to characters restriction. Single segment 2021-04-01 2021-12-31 Unaudited Standalone 1679862000.00 65053000.00 1744915000.00 791268000.00 33672000.00 -54811000.00 139848000.00 4858000.00 45739000.00 228393000.00 1188967000.00 555948000.00 0.00 555948000.00 140608000.00 658000.00 141265000.00 0.00 414683000.00 0.00 0.00 0.00 0.00 414683000.00 -261000.00 414422000.00 414422000.00 0.00 366307000.00 10 11.32 11.32 0.00 0.00 11.32 11.32 Other Expenses 82575000.00 Other Expenses 228393000.00